Universal Time: 11:48  |  Local Time: 11:48 (3h GMT)
Select your timezone:

Mon Sep 23

15:40 - 16:40 Thematic Session: Genetics in precision medicine
TS1 Genetics for precision medicine in transplantation
Shane T Grey, Australia
TS2 Biopsy transcriptomics for diagnosis and research
Jasper Callemeyn, Belgium
Identifying operational tolerance
Megan Sykes, United States
15:40 - 16:40 Thematic Session: Promises of big data and AI - facts or fiction?
TS1 Machine learning model for outcome prediction
Nancy Kwan Man, Hong Kong
TS2 Application of AI in transplant pathology
Weijia Zhang, United States
TS3 Developing transplant registries in LMIC and MIC
Adisorn Lumpaopong, Thailand
15:40 - 16:40 Thematic Session: Uterus-transplantation: Where are we now
TS1 10 years after the first successful uterus transplant: How will the teenage years look?
Mats Brannstrom, Sweden
TS2 Ethical guardrails in uterus transplantation
Anji Wall, United States
TS3 Uterus-specific aspects of alloimmunity and immunosuppression
Paige Porrett, United States
15:40 - 16:40 Thematic Session: Clinical trials design and end-points in transplantation
TS1 Innovative trial design in transplantation
Andrea Viecelli, Australia
TS2 The Parsons Model - ethical implications of research involving those determined dead by neurological criteria
Jayme Locke, United States
TS3 Trials in immunosuppression/Long term in kidney transplantation
Roslyn B. Mannon, United States
15:40 - 16:40 Thematic Session: Organ utilization - do we need to challenge each other to do better?
TS1 The promise of equity in a deceased donor allocation system
Chris Callaghan, United Kingdom
TS2 Strategies to improve non-utilisation rates of deceased donors
Sumit Mohan, United States
TS3 Reducing the risk of donor transmitted disease
Beatriz Dominguez-Gil, Spain
15:40 - 16:40 Thematic Session: Life participation and living well after transplantation
TS1 Living well after transplantation
Bill Wang, Hong Kong
TS2 Work, life, and sex after transplantation
Louise Lerminiaux, Costa Rica
TS3 Prehabilitation into transplant and beyond
Marieke Vandecruys, Belgium
15:40 - 16:40 Thematic Session: Pancreas and islet
TS1 Beta cell replacement (whole pancreas, islet and cell transplantation) within the treatment landscape of type 1 diabetes
Braulio Alejandro Marfil-Garza, Mexico
TS2 Deciphering the immunological enigma of allo-beta cell transplantation: Addressing unresolved questions and embracing the frontiers of knowledge
Lorenzo Piemonti, Italy
TS3 Avoiding the need for immunosuppression in islet transplantation
Sonja Shrepfer, United States

Tue Sep 24

15:40 - 16:40 Thematic Session: Advances in antibody assessment
TS1 ABO antibodies - future perspectives
Lori J. West, Canada
TS2 Advances in AB detection: From Luminex to Eplets and more
Cynthia Kramer, Netherlands
TS3 Applying AB detection techniques in real life
Anne Halpin, Canada
15:40 - 16:40 Thematic Session: Equity and access to transplantation
TS1 Risks to equity in organ allocation introduced by AI
Mamatha Bhat, Canada
TS2 Disparity in access to solid organ transplantation
Lungiswa Mtingi-Nkonzombi, South Africa
TS3 Sex and gender disparities in transplantation access
Bethany Foster, Canada
15:40 - 16:40 Thematic Session: Reproductive care - General
TS1 Gestational outcomes for transplant recipients: A focus on fetal health
Margriet FC de Jong, Netherlands
TS2 Impact of pregnancy on graft function in kidney Tx
Marleen van Buren, Netherlands
TS3 Reproductive planning - why & how
Shilpanjali Jesudason, Australia
15:40 - 16:40 Thematic Session: Cellular therapies
TS1 Dendritic cells - insights from clinical trials
Angus W Thomson, United States
TS2 CAR-Treg optimization
Mohsen Khosravi-Maharlooei, United States
TS3 Adoptive t-cell therapy for infections
Patrizia Comoli, Italy
15:40 - 16:40 Thematic Session: Organ perfusion and preservation
TS1 Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation
Emily R. Thompson, United Kingdom
TS2 Ex-situ machine perfusion (heart, liver, kidney) (standard, oxygenated, hypothermic, normothermic)
Gabriel Oniscu, Sweden
TS3 Cryopreservation
Erik Finger, United States
15:40 - 16:40 Thematic Session: Dealing with post-transplant complications
TS1 De novo malignancy post-transplant
Naoka Murakami, United States
TS2 What's new in vaccines?
Andrew Karaba, United States
TS3 Managing post-transplant metabolic disease
Wai Lim, Australia
15:40 - 16:40 Thematic Session: Kidney transplant surgery
TS1 The best way to procure live donor kidneys: Robotic vs. laparoscopic donor nephrectomy
Chandra Bhati, United States
TS2 Robotic renal transplantation: State of the art
Sangil Min, Korea
TS3 Robotic renal transplantation: A niche approach for selected patients or the future surgical approach for all?
Timucin Taner, United States

Wed Sep 25

15:25 - 16:25 Thematic Session: Surfing the big data wave
TS1 Patient centred outcomes measures
Nicole J Scholes-Robertson, Australia
TS2 Genomics strategies to redefine histocompatibility and risk stratification
Sophie Limou, France
TS3 Is AI better than human in predicting post-transplant outcomes?
Carmen Lefaucheur, France
15:25 - 16:25 Thematic Session: Regenerative medicine
TS1 Regenerative medicine in cardiology
James Chong, Australia
TS2 Overcoming senescence to improve transplant outcome
Anette Melk, Germany
TS3 Tissue engineering and organ fabrication
Rui L. Reis, Portugal
15:25 - 16:25 Thematic Session: Patient-centered care
TS1 Ready-Steady-Go/A blueprint for health care transition in Europe?
Arvind Nagra, United Kingdom
TS2 The therapy in wellness, movement and community
Liz Schick, Switzerland
TS3 Shared decision making in post-transplant care
Gerardo Reyna, Spain
15:25 - 16:25 Thematic Session: Normothermic regional perfusion (A-NRP and TA-NRP)
TS1 Implications of NRP and especially TA-NRP for death determination
Dale Gardiner, United Kingdom
TS2 The surgical approach - the US perspective
Anji Wall, United States
TS3 The surgical approach - the Spanish perspective
Alicia Pérez, Spain
15:25 - 16:25 Thematic Session: Infection complications in transplantation
1 Climate change and Infection - how it affects transplantation
Ilan Schwartz, United States
2 COVID-19 infections and impact on transplant outcomes in the Middle-East
Sibel Gokcay Bek, Turkey
3 Recurrent UTI in solid organ transplant recipient
Deepali Kumar, Canada
15:25 - 16:25 Thematic Session: Minimally invasive recipient surgery: The future is here (Liver)
TS1 How far can we expand the indication of Robot-assisted LDLT?
Dieter C. Broering, Saudi Arabia
TS2 Which is better for graft extraction/insertion? Upper midline incision vs, Pfannenstiel incision
Mohamed Rela, India
TS3 Which is better for graft explant and/or graft implantation? Laparoscopic vs. Robot Assisted
Kwang-Woong Lee, Korea
15:25 - 16:25 Thematic Session: Xenotransplantation’s regulatory road to the clinic
TS1 History of Xenotransplantation and moving to clinical practice
Wayne Hawthorne, Australia
TS2 WHO leadership in developing global strategies for xenotransplantation
Efstratios (Stratos) Chatzixiros, Switzerland
TS3 Moving forward to ensure continuing registration of clinical Xenotransplantation
Leo Hans Buhler, Switzerland
© 2024 TTS 2024